Pharmaceutical composition for preventing or treating myelosuppression comprising an imidazoline derivative compound as an active ingredient

• Main Author: KIM CHAEKYU
• Format: Patent
• Language: English; Korean
• Published: 11.11.2022
• Subjects: FOODS OR FOODSTUFFS; FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BYSUBCLASSES A23B - A23J; HUMAN NECESSITIES; HYGIENE; MEDICAL OR VETERINARY SCIENCE; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OFNUTRITIVE QUALITIES, PHYSICAL TREATMENT; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES

The present invention relates to a pharmaceutical composition for preventing or treating myelosuppression comprising an imidazoline derivative compound as an active ingredient. According to a composition comprising the imidazoline derivative compound or a pharmaceutically acceptable salt thereof as the active ingredient according to one aspect, there is an effect that can be usefully used for the prevention and/or treatment of myelosuppression by reversibly regulating the cell cycle to protect normal cells other than cancer cells during chemotherapy. 이미다졸린 유도체 화합물을 유효성분으로 포함하는 골수억제 예방 또는 치료용 약학적 조성물에 관한 것으로, 일 양상에 따른 이미다졸린 유도체 화합물 또는 이의 약학적으로 허용가능한 염을 유효성분으로 포함하는 조성물에 의하면, 세포주기를 가역적으로 조절하여 화학요법시 암 세포외의 정상세포는 보호함으로써 골수억제 예방 및/또는 치료에 유용하게 사용될 수 있는 효과가 있다.